Clinical trial

Pausing Antiretroviral Treatment Under Structured Evaluation

NCT06031272

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-05-28

PhasePHASE1

Study timeline

Study start (actual)2024-05-28Date precision: day

Registry last updated2026-08-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1-infectionunresolved

Interventions

3BNC117-LS-JDRUG

10-1074-LS-JDRUG

Placebo for 3BNC117-LS-JDRUG

Placebo for 10-1074-LS-JDRUG

Sponsors & collaborators

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infectionslead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06031272 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.